FACS analysis of Stat3/5 signaling reveals sensitivity to G-CSF and IL-6 as a significant prognostic factor in pediatric AML: A Children's Oncology Group report

Blood

Volumn 121, Issue 7, 2013, Pages 1083-1093

  Redell, Michele S ^a   Ruiz, Marcos J ^a   Gerbing, Robert B ^b   Alonzo, Todd A ^c   Lange, Beverly J ^d   Tweardy, David J ^a   Meshinchi, Soheil ^e  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b CHILDREN S ONCOLOGY GROUP   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 6; STAT3 PROTEIN; STAT5 PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; EVENT FREE SURVIVAL; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; IMMUNOSTIMULATION; INFANT; LIGAND BINDING; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PERSONALIZED MEDICINE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RISK ASSESSMENT; SCHOOL CHILD; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

EID: 84874030016     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-04-421925     Document Type: Article

References (28)

1. Wen Z, Zhong Z, Darnell JE Jr. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell. 1995;82(2):241-250.
2. Bewry NN, Nair RR, Emmons MF, Boulware D, Pinilla-Ibarz J, Hazlehurst LA. Stat3 contributes to resistance toward BCR-ABL inhibitors in a bone marrow microenvironment model of drug resistance. Mol Cancer Ther. 2008;7(10):3169- 3175.
3. Zhou J, Bi C, Janakakumara JV, et al. Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML. Blood. 2009;113(17):4052-4062.
4. Benekli M, Xia Z, Donohue KA, et al. Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival. Blood. 2002;99(1):252-257.
5. Mora LB, Buettner R, Seigne J, et al. Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells. Cancer Res. 2002;62(22):6659-6666. (Pubitemid 35364135)
6. Real PJ, Sierra A, de Juan A, Segovia JC, Lopez-Vega JM, Fernandez-Luna JL. Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells. Onco-gene. 2002;21(50):7611-7618. (Pubitemid 35398808)
7. Gouilleux-Gruart V, Gouilleux F, Desaint C, et al. STAT-related transcription factors are constitu-tively activated in peripheral blood cells from acute leukemia patients. Blood. 1996;87(5):1692-1697. (Pubitemid 26068885)
8. Schuringa J-J, Wierenga ATJ, Kruijer W, Vellenga E. Constitutive Stat3, Tyr705, and Ser727 phosphor-ylation in acute myeloid leukemia cells caused by the autocrine secretion of interleukin-6. Blood. 2000;95(12):3765-3770. (Pubitemid 30412848)
9. Spiekermann K, Biethahn S, Wilde S, Hiddemann W, Alves F. Constitutive activation of STAT transcription factors in acute myelogenous leukemia. Eur J Haematol. 2001;67(2):63-71. (Pubitemid 33010380)
10. Steensma DP, McClure RF, Karp JE, et al. JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplained. Leukemia. 2006;20(6):971-978. (Pubitemid 43797287)
11. Hayakawa F, Towatari M, Kiyoi H, et al. Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines. Oncogene. 2000;19(5):624-631. (Pubitemid 30102913)
12. Meshinchi S, Woods WG, Stirewalt DL, et al. Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute my-eloid leukemia. Blood. 2001;97(1):89-94. (Pubitemid 32061246)
13. Irish JM, Hovland R, Krutzik PO, et al. Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell. 2004;118(2):217-228. (Pubitemid 38962577)
14. Redell MS, Ruiz MJ, Alonzo TA, Gerbing RB, Tweardy DJ. Stat3 signaling in acute myeloid leukemia: ligand-dependent and-independent activation and induction of apoptosis by a novel small-molecule Stat3 inhibitor. Blood. 2011; 117(21):5701-5709.
15. Kornblau SM, Minden MD, Rosen DB, et al. Dynamic single-cell network profiles in acute my-elogenous leukemia are associated with patient response to standard induction therapy. Clin Cancer Res. 2010;16(14):3721-3733.
16. Rosen DB, Minden MD, Kornblau SM, et al. Functional characterization of FLT3 receptor signaling deregulation in acute myeloid leukemia by single cell network profiling (SCNP). PLoS One. 2010;5(10):e13543.
17. Kotecha N, Flores NJ, Irish JM, et al. Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates. Cancer Cell. 2008;14(4):335-343.
18. Lange BJ, Smith FO, Feusner J, et al. Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group. Blood. 2008;111(3):1044-1053. (Pubitemid 351213382)
19. Ho PA, Alonzo TA, Gerbing RB, et al. Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group. Blood. 2009;113(26):6558-6566.
20. Gibbs KD Jr, Gilbert PM, Sachs K, et al. Single-cell phospho-specific flow cytometric analysis demonstrates biochemical and functional heterogeneity in human hematopoietic stem and progenitor compartments. Blood. 2011;117(16): 4226-4233.
21. Marvin J, Swaminathan S, Kraker G, Chadburn A, Jacobberger J, Goolsby C. Normal bone marrow signal-transduction profiles: a requisite for enhanced detection of signaling dysregulations in AML. Blood. 2011;117(15):e120-e130.
22. Ozawa Y, Williams AH, Estes ML, et al. Src family kinases promote AML cell survival through activation of signal transducers and activators of transcription (STAT). Leuk Res. 2008;32(6):893-903.
23. Pollard JA, Alonzo TA, Gerbing RB, et al. FLT3 internal tandem duplication in CD34+/CD33-precursors predicts poor outcome in acute myeloid leukemia. Blood. 2006;108(8):2764-2769.
24. Kato T, Sakamoto E, Kutsuna H, Kimura-Eto A, Hato F, Kitigawa S. Proteolytic conversion of STAT3alphato STAT3gamma in human neutrophils. J Biol Chem. 2004;279(30):31076-31080.
25. Ehlers S, Herbst C, Zimmermann M, et al. Granulocyte colony-stimulating factor (G-CSF) treatment of childhood acute myeloid leukemias that overexpress the differentiation-defective G-CSF receptor isoform IV is associated with a higher incidence of relapse. J Clin Oncol. 2010;28(15): 2591-2597.
26. White SM, Ball ED, Ehmann WC, Rao AS, Tweardy DJ. Increased expression of the differentiation-defective granulocyte colony-stimulating factor receptor mRNA isoform in acute myelogenous leukemia. Leukemia. 1998;12(6): 899-906. (Pubitemid 28287213)
27. Spinelli E, Caporale R, Buchi F, et al. Distinct signal transduction abnormalities and erythropoietin response in bone marrow hematopoietic cell sub-populations of myelodysplastic syndrome patients. Clin Cancer Res. 2012;18(11):3079-3089.
28. Hedley DW, Chow S, Shankey TV. Cytometry of intracellular signaling: from laboratory bench to clinical application. Methods Cell Biol. 2011;103: 203-220.